Replies to post #215346 on Biotech Values

[DewDiligence]

ENTA is looking at roughly 35 mil cash burn per quarter for fiscal year 2018.

Not true! The guidance you cited is for gross operating expenses, not cash burn. ENTA will have substantial royalty income on Mavyret during FY2018 (and beyond).